acetazolamide has been researched along with 2019 Novel Coronavirus Disease in 10 studies
Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
| Excerpt | Relevance | Reference |
|---|---|---|
| " The Idiopathic Intracranial Hypertension Treatment Trial was an adult, multicenter study that examined the use of acetazolamide and weight loss on the course of PIH." | 5.12 | Pediatric Intracranial Hypertension: A Spotlight on Imaging, the Idiopathic Intracranial Hypertension Treatment Trial, and COVID-19 Associated Cases. ( Aylward, SC; Brun, BN, 2021) |
| "The patient was diagnosed with ME and hydrocephalus." | 1.72 | Meningoencephalitis and postinflammatory hydrocephalus in the course of COVID-19 disease in newborn - the potential role of acetazolamide as add-on therapy to the standard treatment. ( Bryda, J; Wątroba, SJ, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 10 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brun, BN | 1 |
| Aylward, SC | 1 |
| Vizcarra-Vizcarra, CA | 1 |
| Chávez-Velázquez, E | 1 |
| Asato-Higa, C | 1 |
| Hurtado-Aréstegui, A | 1 |
| Wątroba, SJ | 1 |
| Bryda, J | 1 |
| Finsterer, J | 1 |
| Scorza, FA | 1 |
| Güngör Tunçer, Ö | 1 |
| Nalbantoglu, M | 1 |
| Sengul, EA | 1 |
| Baykan, B | 1 |
| Geier, MR | 1 |
| Geier, DA | 1 |
| Horowitz, RI | 1 |
| Freeman, PR | 1 |
| Luks, AM | 1 |
| Swenson, ER | 1 |
| Habibzadeh, P | 1 |
| Mofatteh, M | 1 |
| Ghavami, S | 1 |
| Roozbeh, J | 1 |
| Deniz, S | 1 |
| Uysal, TK | 1 |
| Capasso, C | 1 |
| Supuran, CT | 1 |
| Ozensoy Guler, O | 1 |
2 reviews available for acetazolamide and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Pediatric Intracranial Hypertension: A Spotlight on Imaging, the Idiopathic Intracranial Hypertension Treatment Trial, and COVID-19 Associated Cases.
Topics: Acetazolamide; Adolescent; Adult; Carbonic Anhydrase Inhibitors; Child; Combined Modality Therapy; C | 2021 |
COVID-19 Lung Injury and High-Altitude Pulmonary Edema. A False Equation with Dangerous Implications.
Topics: Acetazolamide; Altitude Sickness; Betacoronavirus; Carbonic Anhydrase Inhibitors; Coronavirus Infect | 2020 |
8 other studies available for acetazolamide and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Treatment of Focal and Segmental Glomerulosclerosis Secondary to High Altitude Polycythemia with Acetazolamide.
Topics: Acetazolamide; Adult; Altitude; Altitude Sickness; COVID-19; Female; Glomerulosclerosis, Focal Segme | 2022 |
Meningoencephalitis and postinflammatory hydrocephalus in the course of COVID-19 disease in newborn - the potential role of acetazolamide as add-on therapy to the standard treatment.
Topics: Acetazolamide; Child; COVID-19; Humans; Hydrocephalus; Infant, Newborn; Meningoencephalitis; SARS-Co | 2022 |
If SARS-CoV-2 is blamed for causing meningoencephalitis, the virus must be detected in the CSF.
Topics: Acetazolamide; COVID-19; Humans; Male; Meningoencephalitis; SARS-CoV-2; Seizures | 2023 |
Metabolic acidosis during the relapse treatment of idiopathic intracranial hypertension.
Topics: Acetazolamide; Acidosis; Adult; COVID-19; Female; Humans; Pandemics; Pseudotumor Cerebri | 2023 |
Respiratory conditions in coronavirus disease 2019 (COVID-19): Important considerations regarding novel treatment strategies to reduce mortality.
Topics: Acetazolamide; Antiviral Agents; Betacoronavirus; Capillaries; Coronavirus Infections; COVID-19; COV | 2020 |
Three novel prevention, diagnostic, and treatment options for COVID-19 urgently necessitating controlled randomized trials.
Topics: Acetazolamide; Anti-Inflammatory Agents; Anticoagulants; Clinical Laboratory Techniques; Coronavirus | 2020 |
The potential effectiveness of acetazolamide in the prevention of acute kidney injury in COVID-19: A hypothesis.
Topics: Acetazolamide; Acute Kidney Injury; Angiotensin-Converting Enzyme 2; Carbonic Anhydrase Inhibitors; | 2020 |
Is carbonic anhydrase inhibition useful as a complementary therapy of Covid-19 infection?
Topics: Acetazolamide; Acid-Base Equilibrium; Altitude Sickness; Anticonvulsants; Antiviral Agents; Bicarbon | 2021 |